Trial Profile
Safety and efficacy of selexipag in patients with pulmonary artery hypertension: areal life experience
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Jan 2018
Price :
$35
*
At a glance
- Drugs Selexipag (Primary)
- Indications Pulmonary arterial hypertension
- Focus Adverse reactions; Therapeutic Use
- 03 Jan 2018 New trial record